Complex interplay between -catenin signalling and Notch effectors in intestinal tumorigenesis
Grégory Peignon(Inserm), Béatrice Romagnolo(Centre National de la Recherche Scientifique), Isabelle Van Seuningen(Centre National de la Recherche Scientifique), Wulfran Cacheux(Hôpital Privé Jacques Cartier), Christine Perret(Institut de Cancérologie de l'Ouest), Tasuku Honjo(Kyoto University), Noah F. Shroyer(Baylor College of Medicine), Benoît Terris(Unknown), Aurélie Durand(Centre National de la Recherche Scientifique), Pierre Laurent‐Puig(Inserm), Olivier Ayrault(St. Jude Children's Research Hospital)
Cited by 145
Related Papers
Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation
|The Journal of Experimental Medicine|2000|5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activation
|Nature Immunology|2001|2.9k
Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer
|New England Journal of Medicine|2003|2.1k